NEW: DEA Temporarily Extends Flexibilities for Telehealth Prescribing

By: dwc

Yesterday, May 9, 2023, the Drug Enforcement Agency (DEA) and the Substance Abuse & Mental Health Services Administration (SAMHSA) issued a temporary rule that extends telemedicine flexibilities regarding prescription of controlled medications.  The goal of the rule is to ensure a smooth transition for patients and practitioners that have come to rely on the availability […]

Read More

Update on DEA Proposed Rule on Telemedicine Prescribing

By: dwc

In late February 2023 (see NAHC Report), the Drug Enforcement Agency (DEA) proposed a rule intended to govern the prescribing of controlled substances via telemedicine for application at the end of the COVID-19 Public Health Emergency (PHE). The proposed rule focuses on prescribing of a controlled substance via telemedicine consultation by a medical practitioner when no in-person […]

Read More